| Vulnerability for alcohol use disorder and rate of alcohol consumption JL Gowin, ME Sloan, BL Stangl, V Vatsalya, VA Ramchandani American Journal of Psychiatry 174 (11), 1094-1101, 2017 | 144 | 2017 |
| The endocannabinoid system as a target for addiction treatment: trials and tribulations ME Sloan, JL Gowin, VA Ramchandani, YL Hurd, B Le Foll Neuropharmacology 124, 73-83, 2017 | 106 | 2017 |
| Emotion regulation in substance use disorders: A systematic review and meta‐analysis J Stellern, KB Xiao, E Grennell, M Sanches, JL Gowin, ME Sloan Addiction 118 (1), 30-47, 2023 | 89 | 2023 |
| Emotion recognition biases in alcohol use disorder CR Freeman, CE Wiers, ME Sloan, A Zehra, V Ramirez, GJ Wang, ... Alcoholism: clinical and experimental research 42 (8), 1541-1547, 2018 | 55 | 2018 |
| Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant ME Sloan, JL Gowin, J Yan, ML Schwandt, PA Spagnolo, H Sun, ... Addiction biology 23 (1), 474-484, 2018 | 50 | 2018 |
| Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies ME Sloan, CW Grant, JL Gowin, VA Ramchandani, B Le Foll Acta Pharmacologica Sinica 40 (3), 342-350, 2019 | 46 | 2019 |
| The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology J Gowin, ME Sloan, JE Swan, R Momenan, VA Ramchandani Psychopharmacology 236, 775-785, 2019 | 43 | 2019 |
| Differences in decision-making as a function of drug of choice JL Gowin, ME Sloan, VA Ramchandani, MP Paulus, SD Lane Pharmacology Biochemistry and Behavior 164, 118-124, 2018 | 35 | 2018 |
| The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption ME Sloan, TD Klepp, JL Gowin, JE Swan, H Sun, BL Stangl, ... Neuropsychopharmacology 43 (7), 1530-1538, 2018 | 28 | 2018 |
| Targeting neuroinflammation with minocycline in heavy drinkers IL Petrakis, E Ralevski, R Gueorguieva, ME Sloan, L Devine, G Yoon, ... Psychopharmacology 236, 3013-3021, 2019 | 25 | 2019 |
| Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models JL Gowin, M Ernst, T Ball, AC May, ME Sloan, SF Tapert, MP Paulus NeuroImage: Clinical 21, 101676, 2019 | 22 | 2019 |
| High‐risk social drinkers and heavy drinkers display similar rates of alcohol consumption ME Sloan, JL Gowin, R Janakiraman, CD Ester, J Stoddard, B Stangl, ... Addiction biology 25 (2), e12734, 2020 | 21 | 2020 |
| History of suicidality and alcohol craving trajectories during inpatient treatment for alcohol use disorder R Janakiraman, JL Gowin, ME Sloan, ML Schwandt, N Diazgranados, ... Drug and alcohol dependence 209, 107918, 2020 | 10 | 2020 |
| Randomized clinical trials investigating innovative interventions for smoking cessation in the last decade MNS Gendy, C Ibrahim, ME Sloan, B Le Foll Substance Use Disorders: From Etiology to Treatment, 395-420, 2020 | 7 | 2020 |
| GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential RN Dharavath, C Pina-Leblanc, VM Tang, ME Sloan, YS Nikolova, ... Frontiers in Neural Circuits 17, 2023 | 5 | 2023 |
| Characteristics associated with high-intensity binge drinking in alcohol use disorder JL Gowin, ME Sloan, JK Morris, ML Schwandt, N Diazgranados, ... Frontiers in psychology 12, 750395, 2021 | 5 | 2021 |
| Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR* D analysis VM Tang, D Yu, CR Weissman, BDM Jones, G Wang, ME Sloan, ... Journal of Affective Disorders 339, 691-697, 2023 | 4 | 2023 |
| Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies KB Xiao, E Grennell, A Ngoy, TP George, B Le Foll, CS Hendershot, ... Psychopharmacology 240 (7), 1393-1415, 2023 | 4 | 2023 |
| Elevated stearoyl-CoA desaturase 1 activity is associated with alcohol-associated liver disease TD Klepp, ME Sloan, S Soundararajan, CE Ramsden, R Cinar, ... Alcohol 102, 51-57, 2022 | 4 | 2022 |
| Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking … A Bahji, M Danilewitz, M Sloan, V Tang, D Crockford CMAJ 196 (10), E346-E347, 2024 | 2 | 2024 |
